Heart failure (HF) is associated with a significant incidence of lethal cardiac arrhythmias. The molecular mechanisms accounting for these arrhythmias are incompletely defined and will be the basis of study for this new, four-year application. The slower and larger late sodium current (INaL) was originally described by our laboratory in normal and failing hearts and has been recognized as an important contributor to arrhythmia generation. The molecular origin and regulatory mechanisms of INaL, particularly in diseased myocardium, remain largely unknown and will serve as the focus of this proposal.
The specific aims of this proposal will test the following hypotheses: 1) the main a-subunit of the cardiac Na+ channel isoform operates in distinct gating modes and is responsible for INaL in normal and failing myocardium, 2) INaL can be regulated by the membrane micro-environment of the channel, namely by the cytoskeleton and auxiliary beta-subunits, and 3) INaL can be modulated by intracellular signaling pathways involving the Ca2+-sensing protein, calmodulin. Ventricular canine cardiomyocytes isolated from normal hearts and hearts from dogs with chronic HF produced by sequential coronary microembolizations will be used to execute the specific aims. Whole-cell and single-channel voltage clamp techniques will be employed to study the activity of the late Na+ channels in cultured cardiomyocytes with knocked-down genes and/or altered cell-signaling pathways. Knowledge derived from the present proposal may reveal novel targets for the treatment of life-threatening arrhythmias associated with chronic HF.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Lathrop, David A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Henry Ford Health System
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Undrovinas, Nidas A; Maltsev, Victor A; Belardinelli, Luiz et al. (2010) Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure. J Physiol Sci 60:245-57
Maltsev, Victor A; Kyle, John W; Undrovinas, Albertas (2009) Late Na+ current produced by human cardiac Na+ channel isoform Nav1.5 is modulated by its beta1 subunit. J Physiol Sci 59:217-25
Maltsev, Victor A; Kyle, John W; Mishra, Sudhish et al. (2008) Molecular identity of the late sodium current in adult dog cardiomyocytes identified by Nav1.5 antisense inhibition. Am J Physiol Heart Circ Physiol 295:H667-76
Maltsev, Victor A; Undrovinas, Albertas (2008) Late sodium current in failing heart: friend or foe? Prog Biophys Mol Biol 96:421-51
Maltsev, Victor A; Reznikov, Vitaliy; Undrovinas, Nidas A et al. (2008) Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences. Am J Physiol Heart Circ Physiol 294:H1597-608
Undrovinas, Albertas; Maltsev, Victor A (2008) Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem 6:348-59
Maltsev, Victor A; Silverman, Norman; Sabbah, Hani N et al. (2007) Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. Eur J Heart Fail 9:219-27
Undrovinas, Albertas I; Belardinelli, Luiz; Undrovinas, Nidas A et al. (2006) Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol 17 Suppl 1:S169-S177
Maltsev, Victor A; Undrovinas, Albertas I (2006) A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes. Cardiovasc Res 69:116-27
Zicha, Stephen; Maltsev, Victor A; Nattel, Stanley et al. (2004) Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure. J Mol Cell Cardiol 37:91-100